The Joint Clinical Assessment: Anticipating Challenges and Opportunities
Download our Joint Clinical Assessment white paper to learn more about the European Union’s Health Technology Assessment Regulation 2021/2282, set to take effect in January 2025. Our detailed white paper provides an essential overview of the regulations, a brief history, and an in-depth look at the proposed JCA framework, highlighting the challenges and opportunities it presents.
Key perspectives include: 
- Harmonization of HTA tools, procedures, and methodologies
- Reduction of duplication for HTA bodies
- Governance by EUnetHTA21 and Member State HTA Coordination Groups
- Leveraging RWD/RWE
- Opportunities for faster evidence generation and decision making
In this white paper UBC’s Judy Lytle, PhD, MBEE, PMP, Executive Director, Evidence Development Study Solutions, outlines the goals, standards, and anticipated challenges associated with the JCA process. Gain a clear understanding of the new regulations, the JCA framework, and strategies for improving access to medicines and medical technology in the EU.
Get started by completing the form to access our white paper: Joint Clinical Assessment: Anticipating Challenges and Opportunities
Want to know more about us?
Subscribe Now
Want to know more about us?
Subscribe Now
Providers
Thank You for Connecting with UBC
Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.
What You Can Expect Next
Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.
- Leverage automation to move fast
- Always give customers a human to chat to
- Automate customer support and close leads faster
Get Ready to Change Your Business
Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.
Service Request
Bekki Bracken Brown
President & Chief Executive Officer
Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.
With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.